Latest Customer Support News

Yojee enters FY27 with 12 signed MOSAIC customer agreements and $10.45 million in fresh funding, but the freight software company is still loss-making and yet to generate meaningful MOSAIC revenue. Management expects initial billings in the December quarter as it works to convert signed customers into live, billable usage.

Sunrise Energy Metals has put its Syerston scandium project on a stronger financial footing, ending FY2026 with A$115.4 million in cash and a conditional US$400 million debt commitment. The project still faces a decisive sequence of tests: final investment approval, binding offtake agreements, financing conditions and construction execution.

Microba Life Sciences delivered a mixed FY26, with overall revenue slipping 5.8% to $14.76 million and a statutory loss widening 38.7% to $20.7 million. The company’s strategic pivot to core microbiome testing paid off with a 92% surge in core testing revenue and record test volumes in Australia and the UK. Despite the headline loss, underlying loss improved 11% thanks to cost cuts and AI-driven efficiencies. Microba is gearing up for the October launch of its GI Navigator diagnostic and targeting cash flow break-even on a run-rate basis in calendar 2027.

Clever Culture Systems expanded its pharmaceutical customer base to eight in FY26, placing 11 APAS Independence instruments and completing its product offering with a contact plate module. Despite a $2.24 million net loss, the company expects meaningful sales growth in FY27 backed by a robust pipeline and disciplined financial management.

Meridian Energy (NZX:MEL) reported a strong turnaround in FY26 with a $130 million net profit after tax, driven by improved hydro and wind generation, retail growth, and strategic investments in renewable projects and grid flexibility.

Zip Co Limited (ASX: ZIP) reported a 46% rise in net profit to $116.4 million for FY26, driven by strong US and ANZ market growth and record cash earnings of $268.9 million. The company also announced an orderly wind down of its New Zealand operations to focus on its core markets.

ANZ posted a 3Q26 cash profit of AUD 1.90 billion, modestly up on the half-year quarterly average despite a NZD125 million legal provision. The bank’s capital position strengthened, and strategic integration efforts progress on schedule.

Memphasys secures exclusive Felix™ commercialisation agreement in Poland, marking its third European market entry with a two-year contract valued at approximately A$350,000.

DigitalX Limited (ASX:DCC) reported its first cash flow positive quarter driven by strong growth in its Sell My Shares platform and disciplined cost management, while announcing a significant on-market share buy-back and updating its Bitcoin treasury strategy.

FBR Limited has partnered with Industrial Robotics LLC to distribute and support its Mantis™ welding robots across the United States and Canada, targeting key southern states and expanding its footprint without increasing headcount.

Microba Life Sciences has delivered robust FY26 growth in its core microbiome testing business, with revenues up 92% year-on-year and a new GI Navigator product set for launch in September 2026. The company also announced a $7 million annualised cost reduction program as it advances towards cashflow break-even.

DigitalX has achieved its first cashflow positive quarter, driven by record revenue from its Sell My Shares platform and disciplined cost management. The company holds a strategic Bitcoin treasury of over 280 BTC and plans market-neutral trading strategies alongside a substantial share buy-back.